On March 16, 2021, Solid Biosciences joined PPMD for a webinar to provide a safety and efficacy update on the ongoing IGNITE DMD phase I/II clinical study of SGT-001 microdystrophin gene therapy in patients with Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 4 years ago You may also like 48:02 Family Friday: Sibling Relationships 5 years ago Family Friday,Webinars 1:02:19 Making the Most of Your Telehealth Appointments (May 6, 2020) 5 years ago Care Webinars,COVID-19 Webinars,Webinars 47:30 Family Friday: Managing Learning Challenges at Home 5 years ago Family Friday,Webinars 1:00:26 Access to Approved Therapies and Home Care (April 29, 2020) 5 years ago Care Webinars,COVID-19 Webinars,Webinars 54:06 Italfarmaco Provides Givinostat Update (April 22, 2020) 5 years ago Research & Clinical Trial Webinars,Webinars 34:10 Family Friday: Healthy & Fun Cooking at Home 5 years ago Family Friday,Webinars 42:59 Family Friday: COVID-19, Social Distancing, & Quarantine – Coping with Stress and Anxiety 5 years ago Family Friday,Webinars 55:54 COVID-19, Social Distancing & Quarantine: Coping with Stress & Anxiety (April 8, 2020) 5 years ago Care Webinars,COVID-19 Webinars,Webinars «1…1011121314…25»Page 12 of 25
by: Parent Project Muscular Dystrophy
